Waterloo, Canada

Chuyi Liu

This inventor holds 1 USPTO granted patent. Top assignee: Bioinformatics Solutions Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chuyi Liu. Retrieved from https://idiyas.com/inventor/chuyi-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chuyi Liu and Deep-Learning-Based Peptide Sequencing.

Introduction

Chuyi Liu is an inventor associated with Waterloo, Canada, and Bioinformatics Solutions Inc. Her work includes a patent applying deep learning to peptide sequencing from mass spectrometry data.

Latest Patents

Liu is named on one patent, 1 patent: “Systems and Methods for De Novo Peptide Sequencing from Data-Independent Acquisition Using Deep Learning.” The invention uses precursor profiles and fragment-ion spectra from data-independent acquisition mass spectrometry as inputs to a neural network. Its approach aims to improve sequencing accuracy and assemble novel protein sequences without relying on reference databases.

Career Highlights

Liu’s listed patent connects computational methods with proteomics, using neural networks to interpret tandem mass spectrometry data. The work addresses the challenge of identifying peptide sequences from data-independent acquisition measurements.

Collaborations

Liu’s listed coworkers include Lei Xin and Baozhen Shan. The patent is associated with Bioinformatics Solutions Inc.

Conclusion

Chuyi Liu’s patent highlights the use of deep learning to advance de novo peptide sequencing and support the identification of novel protein sequences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…